-
Blitvich BJ, Scanlon D, Shiell BJ, Mackenzie JS, Hall RA, 1999: Identification and analysis of truncated and elongated species of the flavivirus NS1 protein[J]. Virus Res, 60, 67-79. doi: 10.1016/S0168-1702(99)00003-9
-
Charrel RN, Attoui H, Butenko AM, Clegg JC, Deubel V, Frolova TV, Gould EA, Gritsun TS, Heinz FX, Labuda M, Lashkevich VA, Loktev V, Lundkvist A, Lvov DV, Mandl CW, Niedrig M, Papa A, Petrov VS, Plyusnin A, Randolph S, Suss J, Zlobin VI, de Lamballerie X, 2004: Tick-borne virus diseases of human interest in Europe[J]. Clin Microbiol Infect, 10, 1040-1055. doi: 10.1111/j.1469-0691.2004.01022.x
-
Dobler G, 2010: Zoonotic tick-borne flaviviruses[J]. Vet Microbiol, 140, 221-228. doi: 10.1016/j.vetmic.2009.08.024
-
Eyre NS, Johnson SM, Eltahla AA, Aloi M, Aloia AL, McDevitt CA, Bull RA, Beard MR, 2017: Genome-wide mutagenesis of dengue virus reveals plasticity of the NS1 protein and enables generation of infectious tagged reporter viruses[J]. J Virol, 91, e01455-17.
-
Halfmann P, Kim JH, Ebihara H, Noda T, Neumann G, Feldmann H, Kawaoka Y, 2008: Generation of biologically contained Ebola viruses[J]. Proc Natl Acad Sci USA, 105, 1129-1133. doi: 10.1073/pnas.0708057105
-
Hayasaka D, Yoshii K, Ueki T, Iwasaki T, Takashima I, 2004: Subgenomic replicons of Tick-borne encephalitis virus[J]. Arch Virol, 149, 1245-1256. doi: 10.1007/s00705-003-0262-y
-
Khromykh AA, Sedlak PL, Westaway EG, 2000: cis- and trans-acting elements in flavivirus RNA replication[J]. J Virol, 74, 3253-3263. doi: 10.1128/JVI.74.7.3253-3263.2000
-
Lani R, Moghaddam E, Haghani A, Chang LY, AbuBakar S, Zandi K, 2014: Tick-borne viruses: a review from the perspective of therapeutic approaches[J]. Ticks Tick Borne Dis, 5, 457-465. doi: 10.1016/j.ttbdis.2014.04.001
-
Li XF, Li XD, Deng CL, Dong HL, Zhang QY, Ye Q, Ye HQ, Huang XY, Deng YQ, Zhang B, Qin CF, 2017: Visualization of a neurotropic flavivirus infection in mouse reveals unique viscerotropism controlled by host type Ⅰ interferon signaling[J]. Theranostics, 7, 912-925. doi: 10.7150/thno.16615
-
Li JQ, Deng CL, Gu D, Li X, Shi L, He J, Zhang QY, Zhang B, Ye HQ, 2018: Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus[J]. Antivir Res, 150, 148-154. doi: 10.1016/j.antiviral.2017.12.017
-
Lindenbach BD, Rice CM, 1997: trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication[J]. J Virol, 71, 9608-9617.
-
Lo MK, Tilgner M, Bernard KA, Shi PY, 2003: Functional analysis of mosquito-borne flavivirus conserved sequence elements within 30 untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication[J]. J Virol, 77, 10004-10014. doi: 10.1128/JVI.77.18.10004-10014.2003
-
Lo MK, Shi PY, Chen YL, Flint M, Spiropoulou CF, 2016: In vitro antiviral activity of adenosine analog NITD008 against tickborne flaviviruses[J]. Antivir Res, 130, 46-49. doi: 10.1016/j.antiviral.2016.03.013
-
Mason PW, Shustov AV, Frolov I, 2006: Production and characterization of vaccines based on flaviviruses defective in replication[J]. Virology, 351, 432-443. doi: 10.1016/j.virol.2006.04.003
-
Morgenstern JP, Land H, 1990: Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line[J]. Nucleic Acids Res, 18, 3587-3596. doi: 10.1093/nar/18.12.3587
-
Orlinger KK, Hofmeister Y, Fritz R, Holzer GW, Falkner FG, Unger B, Loew-Baselli A, Poellabauer EM, Ehrlich HJ, Barrett PN, Kreil TR, 2011: A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive crossneutralizing antibodies in humans[J]. J Infect Dis, 203, 1556-1564. doi: 10.1093/infdis/jir122
-
Pierson TC, Sanchez MD, Puffer BA, Ahmed AA, Geiss BJ, Valentine LE, Altamura LA, Diamond MS, Doms RW, 2006: A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection[J]. Virology, 346, 53-65. doi: 10.1016/j.virol.2005.10.030
-
Pohjala L, Utt A, Varjak M, Lulla A, Merits A, Ahola T, Tammela P, 2011: Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays[J]. PLoS ONE, 6, e28923-. doi: 10.1371/journal.pone.0028923
-
Qing M, Liu W, Yuan Z, Gu F, Shi PY, 2010: A high-throughput assay using dengue-1 virus-like particles for drug discovery[J]. Antivir Res, 86, 163-171. doi: 10.1016/j.antiviral.2010.02.313
-
Ruzek D, Yakimenko VV, Karan LS, Tkachev SE, 2010: Omsk haemorrhagic fever[J]. Lancet, 376, 2104-2113. doi: 10.1016/S0140-6736(10)61120-8
-
Salat J, Formanova P, Hunady M, Eyer L, Palus M, Ruzek D, 2018: Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use[J]. Vaccine, 36, 7257-7261. doi: 10.1016/j.vaccine.2018.10.034
-
Scholle F, Girard YA, Zhao Q, Higgs S, Mason PW, 2004: transPackaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors[J]. J Virol, 78, 11605-11614. doi: 10.1128/JVI.78.21.11605-11614.2004
-
Shang B, Deng C, Ye H, Xu W, Yuan Z, Shi PY, Zhang B, 2013: Development and characterization of a stable eGFP enterovirus 71 for antiviral screening[J]. Antivir Res, 97, 198-205. doi: 10.1016/j.antiviral.2012.12.010
-
Shi PY, Tilgner M, Lo MK, 2002: Construction and characterization of subgenomic replicons of New York strain of West Nile virus[J]. Virology, 296, 219-233. doi: 10.1006/viro.2002.1453
-
Si L, Xu H, Zhou X, Zhang Z, Tian Z, Wang Y, Wu Y, Zhang B, Niu Z, Zhang C, Fu G, Xiao S, Xia Q, Zhang L, Zhou D, 2016: Generation of influenza A viruses as live but replicationincompetent virus vaccines[J]. Science, 354, 1170-1173. doi: 10.1126/science.aah5869
-
Wang SR, Zhang QY, Wang JQ, Ge XY, Song YY, Wang YF, Li XD, Fu BS, Xu GH, Shu B, Gong P, Zhang B, Tian T, Zhou X, 2016: Chemical targeting of a G-quadruplex RNA in the Ebola virus L gene[J]. Cell Chem Biol, 23, 1113-1122. doi: 10.1016/j.chembiol.2016.07.019
-
Xu LL, Shan C, Deng CL, Li XD, Shang BD, Ye HQ, Liu SQ, Yuan ZM, Wang QY, Shi PY, Zhang B, 2015: Development of a stable Gaussia luciferase enterovirus 71 reporter virus[J]. J Virol Methods, 219, 62-66. doi: 10.1016/j.jviromet.2015.03.020
-
Yin Z, Chen YL, Schul W, Wang QY, Gu F, Duraiswamy J, Kondreddi RR, Niyomrattanakit P, Lakshminarayana SB, Goh A, Xu HY, Liu W, Liu B, Lim JY, Ng CY, Qing M, Lim CC, Yip A, Wang G, Chan WL, Tan HP, Lin K, Zhang B, Zou G, Bernard KA, Garrett C, Beltz K, Dong M, Weaver M, He H, Pichota A, Dartois V, Keller TH, Shi PY, 2009: An adenosine nucleoside inhibitor of dengue virus[J]. Proc Natl Acad Sci USA, 106, 20435-20439. doi: 10.1073/pnas.0907010106
-
Yoshii K, Holbrook MR, 2009: Sub-genomic replicon and virus-like particles of Omsk hemorrhagic fever virus[J]. Arch Virol, 154, 573-580. doi: 10.1007/s00705-009-0345-5
-
Yoshii K, Ikawa A, Chiba Y, Omori Y, Maeda J, Murata R, Kariwa H, Takashima I, 2009: Establishment of a neutralization test involving reporter gene-expressing virus-like particles of tickborne encephalitis virus[J]. J Virol Methods, 161, 173-176. doi: 10.1016/j.jviromet.2009.05.016
-
Yoshii K, Igarashi M, Ito K, Kariwa H, Holbrook MR, Takashima I, 2011: Construction of an infectious cDNA clone for Omsk hemorrhagic fever virus, and characterization of mutations in NS2A and NS5[J]. Virus Res, 155, 61-68. doi: 10.1016/j.virusres.2010.08.023
-
Youn S, Li T, McCune BT, Edeling MA, Fremont DH, Cristea IM, Diamond MS, 2012: Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus[J]. J Virol, 86, 7360-7371. doi: 10.1128/JVI.00157-12
-
Zhang HL, Ye HQ, Deng CL, Liu SQ, Shi PY, Qin CF, Yuan ZM, Zhang B, 2017a: Generation and characterization of West Nile pseudo-infectious reporter virus for antiviral screening[J]. Antivir Res, 141, 38-47. doi: 10.1016/j.antiviral.2017.02.006
-
Zhang HL, Ye HQ, Liu SQ, Deng CL, Li XD, Shi PY, Zhang B, 2017b: West Nile virus NS1 antagonizes interferon beta production by targeting RIG-I and MDA5[J]. J Virol, 91, e02396-16.
-
Zhang QY, Li XD, Liu SQ, Deng CL, Zhang B, Ye HQ, 2017c: Development of a stable Japanese encephalitis virus replicon cell line for antiviral screening[J]. Arch Virol, 162, 3417-3423. doi: 10.1007/s00705-017-3508-9